David Baltimore, Ph.D.

Professor of biology at the California Institute of Technology
and the recipient of the 1975 Nobel Prize in Physiology or Medicine

Bruce Carter, Ph.D.

Former President and CEO of Zymogenetics, Inc. and current Board member of additional biotechnology companies and scientific organizations

Founder, chairman and chief executive officer of Isis Pharmaceuticals

President and chief operating officer of Alnylam Pharmaceuticals

Chief executive officer of Alnylam Pharmaceuticals

Co-founder of several biotechnology companies
and former vice chairman of Cowen & Company

Director, chief operating officer and chief financial officer of Isis Pharmaceuticals

President and chief executive officer of Regulus Therapeutics

microRNA Insights

Kleanthis G. Xanthopoulos, Ph. D.
President & Chief Executive Officer
"The Impact of microRNA Medicines"

Garry E. Menzel, Ph. D.
Chief Operating Officer & Executive Vice President of Finance
"Business Strategy and Focus"

Neil W. Gibson, Ph. D.
Chief Scientific Officer
"microRNAs as a New Class of Drug Targets"

Mary Glanville
Senior Vice President of Human Capital
"Culture and Core Values"